4,000
Participants
Start Date
July 31, 2015
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
[StroMed + platelet rich plasma (PRP)]
Patients will be treated with autologous StroMed obtained by the Adipose Ultrasonic Cell Recovery Unit and Platelet Rich Plasma processed by the RegenLab (RegenKit BCT-3) PRP product each as direct injections to the affected joints at the time of initial treatment. Thereafter the affected joints will be treated as direct injections to the joint with Platelet Rich Plasma processed by the RegenLab (RegenKit BCT-3) PRP product. Day 0 \[StroMed + platelet rich plasma (PRP)\], Days 7 and 14 \[PRP\]
RECRUITING
VivaTech International, Inc., Grove City
VivaTech International, Inc.
INDUSTRY